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Summary 
Propriocidal regulation of T  cells refers to apoptosis induced by inerleukin 2 (Ib2) activation 
with subsequent antigen receptor stimulation. We examined whether natural killer (NK) cells 
exhibited cytokine- and ligand-induced death similar to activated T  cells.  Peripheral NK cells 
were examined for ligand-induced death using antibodies to surface moieties (CD2, CD3, CD8, 
CD16, CD56), with and without prior activation of II:2. Only those NK cells stimulated first 
with Ib2 and then with CD16 exhibited ligand-induced death; none of the other antibody stimuli 
induced this phenomenon. Next we examined various cytokines (IL-2, IL-4, I1.-6, IL-7, II.,12, 
I1.-13, interferon c~ and 3') that can activate NK cells and determined if CD16-induced killing 
occurred. Only Ib2 and Ib12 induced NK cell death after occupancy of this receptor by ag- 
gregated immunoglobulin or by eross-linking with antireceptor antibody. The CD16-induced 
death was inhibited by herbimycin A, indicating that cell death was dependent upon protein 
tyrosine kinases.  Identical to T  cells, the form of cell death for NK cells was demonstrated to 
be receptor-induced apoptosis.  Overall these data indicate that highly activated NK cells mediate 
ligand-induced apoptosis via signaling molecules like CD16.  Whereas the propriocidal regula- 
tion ofT cells is antigen specific, this is not the case for NK cells due to the nature of the receptor. 
The clinical implications of this finding are considered. 
S 
timulation  of T  cells  via  their  antigen  receptor  can 
induce proliferation or cell death. This programmed cell 
death or apoptosis can occur in thymocytes and lymphocytes 
(1-3) and is a mechanism of negative selection (4, 5). This 
also can occur in mature T cells and has been suggested to 
be a mechanism for tolerance. The precise mechanism in lym- 
phocytes by which the "choice" is made to proliferate or die 
is not well understood (6-11).  It has been demonstrated that 
high doses of antigen can lead to a paradoxical suppression 
of the immune response that is termed high zone tolerance. 
A proposed mechanism to explain this phenomenon is based 
on the recent finding that T cells that have previously been 
exposed to I1..2 and then stimulated via their TCRs undergo 
apoptosis (10). This has been termed propriocidal regulation 
and is thought to represent feedback inhibition of T  lym- 
phocytes by which selective killing of specific T  cell clones 
might occur. 
While  NK  cells  fail  to  rearrange TCR  subunits,  they 
nonetheless share a number of features with T cells, including 
expression of surface molecules and secretion of some of the 
same cytokines (12-14).  T and NK cells also are developmen- 
tally related; however, unlike T cells, many of the details of 
NK cell development are poorly characterized. Like T cells, 
NK cells respond dramatically to Ib2 (12, 13). After stimu- 
lation with this cytokine, NK cells proliferate, secrete other 
cytokines (like IFN-3,), and have expanded cytolytic activity 
(termed lymphokine-activated killing). Because of this last 
activity, 1I.-2 has been used clinically in the treatment of malig- 
nancies (15,  16). 
We and others have documented many similarities between 
TCR-mediated signaling and Fc receptor (FcR)-mediated sig- 
naling (17-19).  The NK FcR (CD16) utilizes a chain first 
described in association with the TCR,  the ~" chain. Addi- 
tionally the NK FcR activates a nonreceptor protein tyrosine 
kinase and ~" is phosphorylated on tyrosine residues as occurs 
with TCR cross-linking. Finally, inhibition of protein tyro- 
sine kinases block both TCR- and FcR-mediated signaling (19). 
Because of the similarities in NK- and TcR-mediated sig- 
naling and because both NK and T  cells have dramatic re- 
sponses  to IL-2, we sought to determine if NK cells might 
undergo apoptosis in response to occupancy of the FcR if 
the cells had been preactivated with cytokines, like Ib2. 
Materials  and Methods 
Cell Culture.  Cells  were cultured in RPMI 1640 supplemented 
with 2% fetal bovine serum, and 4 mM glutamine (Biofluids Inc., 
Rockville, MD) at 37~  in an atmosphere of 5%  CO2. 
Isolation of  Large Granular  Lymphocytes.  Large  granular lympho- 
cytes were obtained from buffy coats of leukophoresed normal, 
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ther purified from contaminating T cells using antibody depletion. 
Cytotoxicity Assay.  Evaluation of cell death was accomplished 
using two methods. (a) Trypan blue exclusion.  Cells were evalu- 
ated in the presence of 0.4% trypan blue visually. (b) Flow cytom- 
etry. Cells were evaluated for exclusion  of propidium iodide (PI) 
on the FACSort  |  Flow Cytometer (Becton Dickinson & Co., Moun- 
tain View, CA). Using this method, cells also could be stained with 
FITC and evaluated  for subset  markers. 
Cytokines and Treatments.  The following cytokines were used: 
Ib2 (1,000 IU/ml); I1.,4 (500 U/ml); ID6 (1,000 U/ml); Ib7 (1,000 
U/￿9  II.,12 (50 U/￿9  I1.,13 (100 ng/ml); IFN-~ (1,000 U/ml); 
and IFN-  7 (1,000 U/ml). All cytokines except Ib12 and Ib13 were 
provided by the Biological  Response Modifiers  Program Reposi- 
tory. I1.-12 was provided by Genetics Institute (Cambridge, MA). 
I1.,13 was provided by Dr.  P. Ferrara  (Sanofi Elf Bin Recherches, 
Lebege,  France).  Lymphocytes (5  x  106 cells) were treated for 
48 h with cytokines, washed with HBSS, then treated with anti- 
bodies (10 #g/￿9  with or without goat anti-mouse IgG (20/xg/ml) 
or with aggregated lg (50/~g/ml) for 0-4 h at 37~  At various 
times,  the cells were analyzed for cell death or apoptosis. 
FACS  ~ Tunnel Assay (Apoptosis).  Labeling of nicked DNA was 
assayed using a modified nick translation assay on the flow cytom- 
eter (21). Briefly, cells were fixed with formaldehyde, permeabil- 
ized with methanol, and the degree of nuclear damage was evalu- 
ated  by performing a  nick  translation  assay using  FITC-dUTP 
(Boehringer  Mannheim  Corp.,  Indianapolis,  IN).  Cells  were 
enumerated on a FACSort |  Flow Cytometer (Becton-Dickinson 
& Co.,  Mountain View,  CA). 
Results 
TCR-dependent  apoptosis  after  Ib2  activation  has been 
proposed as a mechanism of extrathymic tolerance. Because 
of the documented similarities between T  and NK cells, we 
first sought to determine if a similar phenomenon occurs in 
NK cells.  NK cells were tested immediately after purification 
or after 48  h  of IL-2 activation for induction of cell death. 
When cells were treated with CD3  (as a negative control), 
CD56, or CD16, no cell death was observed with these ligands 
even if these antibodies were cross-linked with goat anti-mouse 
(GUM)  (Fig.  1 A).  However, if the cells were first activated 
with  II.-2,  subsequent cross-linking  of the FcR with  anti- 
CD16 antibody and GaM induced a rapid cell death as deter- 
mined by trypan blue exclusion (Fig.  1 B). Anti-CD16 alone 
induced cell death with slower kinetics, but of similar mag- 
nitude at time points of >12 h.  Neither CD3 nor CD56 in- 
duced any cell death, regardless of whether or not GuM was 
used to cross-link these antibodies. Similar to activated T cells, 
these data indicated that activated but not resting NK cells 
could be induced to death by strong surface receptor activation. 
To utilize a quantitative procedure to measure cell death, 
flow cytometric analysis  (using PI uptake) was used with a 
panel of monoclonal antibodies (CD3, CD8, CD2,  CD56, 
CD16)  plus  GuM  on purified  NK cells (Fig.  1  C).  Again 
after preactivation with II--2, CD16 cross-linking induced cell 
death.  Because NK cells also can be activated by other sur- 
face molecules such  as  CD2  (22-24),  we next  examined if 
this ligand-induced killing was specific for CD16 or if it could 
occur with other receptor molecules. As shown in Fig.  1 C, 
CD2 failed to induce cell death.  When the flow cytometry 
was performed using GaM-FITC (to enumerate the antibody- 
positive cells and to cross-link the receptor),  i>75%  of the 
CD16+  cells were dead at 2 h  (not shown).  The cell death 
by trypan blue exclusion (not  shown)  and  flow cytometry 
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Figure  1.  Receptor-induced 
death of NK lymphocytes.  (A and 
B) Purified  populations  of CD56 + 
NK  cells (970%  CD56+)  were 
tested immediately  after  purification 
(A) or activated  for 48 h with 1,000 
U of  Ib2 (B). The  cells  were  treated 
with  CD3  (q,  ￿9  +GUM); CD56 
(O,  ￿9  +GUM); or CD16 (l-l,  ￿9 
+  GaM),  followed  by  goat 
anti-mouse  lg.  Values represent 
trypan blue evaluation  of  cell death 
and  are representative of four or 
more eiperiments. (C) Ib2-acti- 
vated NK celLs  were assayed  by flow 
cytometry using GuM IgG-HTC. 
The cells were washed and treated 
with GaM alone (+); CD3 (A); 
CD8 (@); CD2 (￿9  CD56 (0); 
or CD16 (￿9  followed by goat 
anti-mouse  Ig.  Values represent 
evaluation  of cell  death and are rep- 
resentative  of  four experiments.  (D) 
Using CD16 (10 gg/ml)  or  ag- 
gregated  Ig (50  ~g/ml),  the  induced 
cell  death of  control  (￿9  or Ib2- 
activated  (￿9  NK  celLs  were  deter- 
mined at 3 h by flow cytometry. 
Values are representative  of two ex- 
periments. using PI was similar in percent cell death.  Thus although 
both CD16  and CD2 have both been reported (22-24)  to 
be activating for NK cells, only CD16 was able to induce 
death. In addition,  to ensure that occupancy of the receptor 
with a more physiologically relevant ligand resulted in cell 
death, aggregated Ig (rabbit,  mouse, and human) were ex- 
amined (Fig. 1 D). All aggregated Igs tested induced death. 
The kinetics of the rabbit  Ig were more rapid than either 
mouse or human Ig, but all achieved similar levels at later 
time points  (not shown). 
Because propriocidal regulation of T cells involves apop- 
tosis, we next determined if the anti-CD16-induced death 
in NK cells also involved genomic DNA degradation.  Cells 
were activated for 48 h in IL-2, washed,  then treated with 
CD3, C056, or CD16 and GaM for 2 h. Nuclear degrada- 
tion was determined by flow cytometry measuring incorpo- 
ration of FITC-UTP. Fig. 2 A shows that significant nuclear 
degradation  occurred after treatment with C016, but not 
with other antibodies. 
Previously, FcR-mediated signaling has been shown to be 
dependent upon protein tyrosine kinase activity. Therefore, 
we next determined whether kinase inhibitors  could block 
the CD16-induced  death. NK cells were activated for 48 h 
in Ib2. The protein tyrosine kinase inhibitor, herbimycin A, 
was added at  -6 h, since it requires pretreatment for several 
hours to mediate inhibition (19), then was removed during 
the assay. Staurosporin, a less specific  but more rapidly acting 
kinase inhibitor than herbimycin A, was added during the 
assay period. Fig. 2 B shows the effect of several  doses of both 
inhibitors. Herbimycin strongly inhibited FcR-dependent cell 
death at both 3 and 1/~M concentrations. Staurosporin only 
potently inhibited  at  10 -7  M,  a  concentration  that  also 
blocks tyrosine kinase activity  (25). 
Since Ib2 previously has been shown to induce a rapid ac- 
tivation of NK cells and now has been shown to prime NK 
cells for CD16-induced killing, we examined a panel of addi- 
tional cytokines to determine if any other cytokines had the 
capacity of priming NK cells in a manner similar to I1.-2. 
Cells were treated for 48 h with medium, Ib2, IL-4, Ib6, 
lb7, IL12, ILl3, IFN-ot, and IFN-% then analyzed by cross- 
linking cells with CD2, CD3, CD56, and CD16.  As seen 
in Fig. 1, untreated NK cells demonstrated some low level 
susceptibility, but only Ib2 and II.,12 were able to strongly 
prime NK cells for susceptibility to CD16-induced  killing 
(Table 1). IFN-oe resulted in a modest increase.  The remainder 
of the cytokines were not different from the low level of  back- 
ground killing induced when cells were cultured in medium. 
The pattern was similar when aggregated Ig was used as a 
stimulus rather than anti-CD16 (data not shown). In parallel 
experiments (not shown) both Ib2 and Ib12 resulted in anti- 
CD16-induced apoptosis, resulting in parallel nuclear degra- 
dation to that shown in Table 1. 
In  addition,  since  CD16  involves engagement of the 
FcyRIII, we determined if antibody-coated target cells would 
induce similar events. Aliquots of medium- and Ib2-pretreated 
cells were cultured with the NK-resistant target (FeMX) for 
3 h then analyzed visually for cell death of effectors (Table 
1). Neither the total population of NK cells nor the target- 
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Figurr  2.  (A) Examination of nuclear degradation in FcR-mediated cell 
death.  Purified  populations  of CD56 §  cells  (80%  CD56 +  and  55% 
CD16 § ) were activated for 48 h with 1,000 U, the cells were washed and 
treated with CD3 (  ), CD56 (...-), or CD16 (----) followed by 
goat anti-mouse Ig for 2 h. Cells were assayed for nuclear degradation 
by measurement of FITC-UTP incorporation. (B) Effect of kinase inhibi- 
tors on CD16-induced death of IL2-activated NK cells. Purified popula- 
tions of CD56 * cells (970% CD56 +) were activated for 48 h with 1,000 
U,  the  cells  were  washed  and  treated  with  CD16  followed  by  goat 
anti-mouse lg. Values represent evaluation of percent inhibition of CD16 * 
cell death using a GaM-FITC, where the CD16 plus GaM induced 23%, 
37%,  and 57% death of the CD16"  cells at 0.5,  1.0, and 2 h, respec- 
tively. Cells were treated with herbimycin A at 3 #M (O) or 1 #tM (V) 
and staurosporin at 10- M (A) or 10-s M (0). Herbimycin A treatment 
began at - 6 h and removed from the assay, while staurosporin was added 
at  -30 min and not washed from the assay. 
bound effectors were induced by antibody-coated targets to 
death. 
Discussion 
TCR engagement and the resulting  apoptosis has been 
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None*  IL-2  IL-4  IL-6  IL-7  IL-12  IL-13  IFN-a  IFN-3, 
Medium  0.8  0.6  0.8  0.6  0.3  0.2  0.2  0.5  0.4 
CD2  -6.3  -3.3  -4.6  -8.2  -2.1  3.3  -5.9  -3.4  -5.2 
CD3  0.9  2.0  1.4  1.4  0.6  3.2  0.7  1.4  2.9 
CD56  2.0  3.4  1.5  0.5  -0.6  3.4  0.3  3.1  1,2 
CD16  9.9  33.3  9.3  13.8  13.5  35.6  13.7  19.6  9.9 
NT  IL-2 
Targetst  Total/Bound  Total/Bound 
FeMX  <I/NDS  1.0/1.3 
FeMX/Ab  3.0/0.9  1.9/1.8 
" Cells were incubated  for 48 h with indicated  cytokine at  the concentration  indicated  in Materials  and  Methods.  Cells were analyzed  for kill- 
ing by PI exclusion  using  a flow cytometer.  Values represent  percent  Pl-positive (dead) cells. 
* NK cells cultured with medium or IL-2 were mixed for 3 h with FeMX targets  (untreated  or coated  with rabbit  anti-FeMX  antibody)  at  a 
1:1  ratio.  Cells were enumerated  for cell death  by visual enumeration  of total lymphocytes  or by counting only target-bound  effectors.  The 
percent  dead were based on cell counts of ~100  cells. 
s ND indicates not determined  due to lack of sufficient binding. 
postulated as an important process in thymic education and 
extrathymic tolerance (4, 5, 8). The balance between activa- 
tion and apoptosis is likely due to a variety of signals received 
by T cells, These signals can determine the fate of cells be- 
tween death and proliferation. One such factor appears  to 
be preexposure to I1,2. This aspect of T cell physiology can 
be exploited clinically (11). In this study, we have examined 
whether similar signals  would result in activation-induced 
death in NK cells. While NK cells do not have a well-defined 
antigen receptor, they do have a receptor that can bind im- 
mune complexes. Indeed our studies indicate that only cross- 
linking the NK FcR was able to mediate ligand-induced death, 
whereas other molecules on NK cells such as CD2,  CD8, 
and CD56 were incapable. This ligand-induced death did not 
occur unless the NK cells were activated with I1,2 or Ib12 
before receptor cross-linking. In addition, similar to reports 
with T cells, cell death involved apoptosis. The CD16-induced 
apoptosis observed with NK cells is of interest, as the NK 
FcR like the TCR of T cells, is comprised of a ~" chain (17, 
18) that is rapidly phosphorylated after receptor engagement. 
CD2 has been shown to trigger NK cells for cytolytic and 
secretory functions (22-24).  Previous studies have demon- 
strated that CD16 is a potent ligand that releases granule serine 
proteases  (23),  known to be a major component of NK cell 
granules. 
It is interesting that only II,2 and I1,12 were able to acti- 
vate/prime NK cells for CD16-  or aggregated Ig-induced 
apoptosis.  Many of the other cytokines tested are able to acti- 
vate NK cytotoxicity (IL-6, Ib7, IFN-ot, and IFN-3, ), or in- 
duced gene transcription (II.,6, IL-7, I1,13, IFN-c~, and IFN- 
"r)- The exact nature of the activation signal required for 
receptor-induced killing is unknown; however, both Ib2 and 
Ib12 induce NK cell proliferation, a demonstrated require- 
ment  for  TCR-induced  apoptosis.  The  inability  of  the 
antibody-coated tumor targets to induce a similar cell death 
using identical effectors suggest that cell-cell interactions de- 
liver a different qualitative and probably quantitative signal 
to the NK cells than total receptor cross-hnking using CD16 
or aggregated Ig. Cell-cell interactions involve numerous other 
ligands, including integrins, and engage only a small per- 
centage of the cell membrane. Possibly these other interac- 
tions regulate the receptor process to avoid effector cell damage. 
Alternatively, the stimulus induced by an Ig-bearing target 
causes ligation of relatively few receptors and simply may be 
a suboptimal stimulus. Further elucidation of the mechanism 
of CD16-induced cell death would provide a better under- 
standing of the lack of antibody-coated targets to induce similar 
events. 
These findings clearly have relatively important implica- 
tions clinically as I1,2 has been used extensively in the treat- 
ment of various malignancies.  This treatment causes dramatic 
expansion of NK cells with increased lytic activity (15, 16). 
These results imply that high dose I1,2 therapy could cause 
in vivo apoptotic death of NK cells.  If I1,2-activated NK 
ceils encounter immune complexes, they could be neutral- 
ized by the processes described in this study. This possibility 
will need to be clarified in future studies. 
At the present time, the physiologic role of FoR-dependent 
apoptosis in Ib2/I1,12-activated NK cells is unclear. Whether 
NK cells are selected during ontogeny is still unclear, though 
there is expanding evidence supporting the recognition of 
self and nonself by NK cells. The role of such processes  in 
positive and negative selection and tolerance in NK cells are 
less defined than in T cells. Since both CD2 and CD8, which 
react with NK cells, failed to demonstrate activation-induced 
cell death, it is interesting to speculate that the association 
of  ~'-chain with  the  CD16  (17, 18)  is  required  for  this 
phenomenon. To date, no other cell surface receptors in NK 
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has been shown to occur early in fetal thymus development 
and could play an important role in the differentiation of T 
cells and NK cells during ontogeny. It is conceivable  that 
this receptor might function in a negative selection for both 
NK and T cells. The physiological role of this process in the 
periphery is less clear and one possibility is that it is vestigial. 
Alternatively, like T cells, this may be a mechanism to dampen 
an exuberant immune and inflammatory response. Unlike T 
cells, though, where such a process would be proposed to 
prevent and regulate self-reactive cells, one could postulate 
that with NK cells this process might be involved in regula- 
tion of inflammation involving NK cells. In this case the term 
propriocidal regulation would not be apt, as NK cells do not 
produce large quantities of I1:2 or Ib12.  Nonetheless, the 
finding that activated NK cells undergo apoptosis in response 
to FcR-mediated stimulation has implications both clinically 
and, perhaps, for NK cell ontogeny. It also underscores  the 
similarities  in function of T  cells and NK cells. 
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